| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084 |
| filingDate |
2003-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743747a9f4910dac212531473ceaf68f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8d9c9da69736dc8161230a6f9d6972b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da47ddbccb1ba75c8f8f2fe31d0c953c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b1b3b5039e38ba13f912f724c9b96b4 |
| publicationDate |
2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004214789-A1 |
| titleOfInvention |
Therapeutics |
| abstract |
The use of a compound of formula (Ia): n n n wherein A and B are independently selected from a cyclic ring, wherein each of which cyclic rings A and B may be optionally substituted at at least one ring position; and n L is a suitable linker; n or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting ADP-ribosyl cyclase. |
| priorityDate |
2001-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |